NCT03431740 is a clinical trial in Radiotherapy, sponsored by University of Zurich.

Who is sponsoring NCT03431740?

NCT03431740 is sponsored by University of Zurich.

What condition does NCT03431740 study?

NCT03431740 studies Radiotherapy.

Is NCT03431740 still recruiting?

NCT03431740 is currently terminated. Last updated 20 April 2021.

Last reviewed 2021-04-20 · How we verify

NCT03431740

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FENO, Extended NO Analysis and NO/CO Diffusing Capacity in Thoracic Radiation Therapy

Terminated Last updated 20 April 2021

What this trial tests

trial in Radiotherapy in 3 participants. Terminated before completion.

Timeline

15 February 2018

Primary endpoint
1 April 2021

1 April 2021

Quick facts

Lead sponsor	University of Zurich
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	3
Start date	15 February 2018
Primary completion	1 April 2021
Estimated completion	1 April 2021
Sites	1 location across Switzerland

Conditions studied

Radiotherapy — all drugs for Radiotherapy →

Sponsor

University of Zurich

Who can join

18 and older, any sex, with Radiotherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to investigate the impact of thoracic radiation therapy on diffusion capacity of the lung (primary endpoint: diffusion capacity for nitric oxide, DLNO) and on exhaled nitric oxide.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Radiotherapy

Currently open trials in the same condition.

NCT07493928 — HPV After chemoRadioTherapy · recruiting
NCT07378631 — Association Between Clinical Subtypes and Prognosis in Radiation Rectal Injury · recruiting
NCT07339488 — Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal · Phase 2 · active not recruiting
NCT07469267 — Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases · NA · recruiting
NCT07447570 — Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC · Phase 2 · recruiting

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03431740 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 20 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03431740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing